User profiles for Mark Fitzgerald

JM FitzGerald

- Verified email at vch.ca - Cited by 51595

Mark Fitzgerald

- Verified email at monash.edu - Cited by 9046

Mark Fitzgerald

- Verified email at email.chop.edu - Cited by 4449

Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): Use of a cluster‐size threshold

SD Forman, JD Cohen, M Fitzgerald… - Magnetic …, 1995 - Wiley Online Library
The typical functional magnetic resonance (fMRI) study presents a formidable problem of
multiple statistical comparisons (ie, > 10,000 in a 128 x 128 image). To protect against false …

Global strategy for asthma management and prevention: GINA executive summary

…, J Bousquet, JM Drazen, M FitzGerald… - European …, 2008 - Eur Respiratory Soc
Asthma is a serious health problem throughout the world. During the past two decades, many
scientific advances have improved our understanding of asthma and ability to manage and …

Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report

…, MA Detry, EJ Duffy, LJ Estcourt, M Fitzgerald… - Medrxiv, 2021 - medrxiv.org
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …

Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial

…, M de Jong, M Detry, L Estcourt, M Fitzgerald… - Jama, 2020 - jamanetwork.com
Importance Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19)
is limited. Objective To determine whether hydrocortisone improves outcome for …

[HTML][HTML] Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an …

…, O van Hecke, MA Detry, CT Saunders, M Fitzgerald… - The Lancet, 2023 - thelancet.com
Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …

Tiotropium in combination with placebo, salmeterol, or fluticasone–salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial

…, K Chapman, N Zamel, M FitzGerald… - Annals of internal …, 2007 - acpjournals.org
Background: Treatment of moderate or severe chronic obstructive pulmonary disease (COPD)
with combinations of inhaled corticosteroids, long-acting β-agonists, and long-acting …

Inhibition of NF‐kappaB/Rel induces apoptosis of murine B cells.

…, SL Schauer, M Arsura, D Katz, MJ FitzGerald… - The EMBO …, 1996 - embopress.org
Apoptosis of the WEHI 231 immature B cell lymphoma line following membrane interaction
with an antibody against the surface IgM chains (anti‐IgM) is preceded by dramatic changes …

Decision curve analysis

M Fitzgerald, BR Saville, RJ Lewis - Jama, 2015 - jamanetwork.com
Decision curve analysis (DCA) is a method for evaluating the benefits of a diagnostic test
across a range of patient preferences for accepting risk of undertreatment and overtreatment to …

[HTML][HTML] Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label …

…, N Berry, MA Detry, C Saunders, M Fitzgerald… - The Lancet, 2021 - thelancet.com
Background A previous efficacy trial found benefit from inhaled budesonide for COVID-19 in
patients not admitted to hospital, but effectiveness in high-risk individuals is unknown. We …

Tuberculosis among health care workers

…, A Fanning, L Yuan, M Fitzgerald - New England Journal of …, 1995 - Mass Medical Soc
The risk of tuberculosis among health care workers was substantial in the era before antibiotics
1 but declined rapidly after 1950 because of the lower incidence of the disease in the …